Ignite Creation Date:
2024-05-06 @ 3:53 AM
Last Modification Date:
2024-10-26 @ 11:40 AM
Study NCT ID:
NCT02404051
Status:
UNKNOWN
Last Update Posted:
2016-06-15
First Post:
2015-01-26
Brief Title:
Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
Sponsor:
Consorzio Oncotech
Organization:
Consorzio Oncotech
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Breast Cancer |
| Breast Cancer |
| Hormone Receptor Positive Tumor |
| Human Epidermal Growth Factor 2 Negative Carcinoma of Breast |
| Locally Advanced Malignant Neoplasm |